Stock comparison
Celestica
Lam Research
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
CLS
Celestica
Market cap
$41.91B
Sector
Technology
LRCX
Lam Research
Market cap
$356.06B
Sector
Technology
Overall winner
Lam Research LRCX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | CLS | LRCX | Winner |
|---|---|---|---|
| Warren Buffett | 52C | 78B | LRCX |
| Benjamin Graham | 76B | 88A | LRCX |
| Philip Fisher | 55C | 76B | LRCX |
| Peter Lynch | 55C | 69B | LRCX |
| Joel Greenblatt | 69C | 84C | LRCX |
| Charlie Munger | 44D | 86A | LRCX |
| Terry Smith | 38D | 88A | LRCX |
Side-by-side metrics
| Metric | CLS | LRCX |
|---|---|---|
| Market cap | $41.91B | $356.06B |
| P/E (TTM) | 43.6x | 53.0x |
| EV/EBIT | 38.8x | 60.2x |
| ROIC (TTM) | 29.23% | 42.79% |
| Gross margin | 11.61% | 49.98% |
| Net margin | 6.95% | 30.94% |
| Revenue CAGR 5y | 22.3% | 5.96% |
| EPS CAGR 5y | 73.03% | 11.27% |
| Debt / Equity | 0.4x | 0.4x |
| Dividend yield | 0.0% | 0.35% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
CLS leads on
- EPS CAGR 5y73.03%vs 11.27%+85%
- Revenue CAGR 5y22.3%vs 5.96%+73%
- EV/EBIT38.8xvs 60.2x+35%
- P/E (TTM)43.6xvs 53.0x+18%
LRCX leads on
- Dividend yield0.35%vs 0.0%+100%
- Market cap$356.06Bvs $41.91B+88%
- Net margin30.94%vs 6.95%+78%
- Gross margin49.98%vs 11.61%+77%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.